A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies
NCT00741403
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Cancer
Metastatic Cancer
Lymphoma
Solid Tumors
Advanced Malignancies
Interventions
DRUG:
CPI-613
Sponsor
Cornerstone Pharmaceuticals